Prenetics Global Limited (PRENW)
USD 0.01
(19.0%)
USD 0.01
(19.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.36 Million USD | -64.35% |
| 2022 | 6.64 Million USD | 26.18% |
| 2021 | 5.26 Million USD | 215.43% |
| 2020 | 1.66 Million USD | 85.63% |
| 2019 | 899.54 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.18 Million USD | 35.21% |
| 2024 Q1 | 1.74 Million USD | -26.19% |
| 2023 Q3 | 5.25 Million USD | -12.88% |
| 2023 FY | 2.36 Million USD | -64.35% |
| 2023 Q4 | 2.36 Million USD | -54.93% |
| 2023 Q2 | 6.03 Million USD | -5.81% |
| 2023 Q1 | 6.4 Million USD | -3.6% |
| 2022 Q2 | 14.14 Million USD | -15.93% |
| 2022 Q1 | 16.82 Million USD | 219.37% |
| 2022 Q4 | 6.64 Million USD | -52.82% |
| 2022 FY | 6.64 Million USD | 26.18% |
| 2022 Q3 | 14.08 Million USD | -0.39% |
| 2021 FY | 5.26 Million USD | 215.43% |
| 2021 Q1 | 28.3 Million USD | 73.9% |
| 2021 Q3 | 434.26 Million USD | 37762147.91% |
| 2021 Q4 | 5.26 Million USD | -98.79% |
| 2021 Q2 | 1150.00 USD | -100.0% |
| 2020 Q4 | 16.27 Million USD | 0.0% |
| 2020 FY | 1.66 Million USD | 85.63% |
| 2019 FY | 899.54 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bionano Genomics, Inc. | 87.94 Million USD | 97.306% |
| Star Equity Holdings, Inc. | 3.6 Million USD | 34.348% |
| CareDx, Inc | 34.22 Million USD | 93.076% |
| Exact Sciences Corporation | 2.55 Billion USD | 99.907% |
| Exagen Inc. | 23.72 Million USD | 90.011% |
| Inotiv, Inc. | 417.64 Million USD | 99.433% |
| Guardant Health, Inc. | 1.35 Billion USD | 99.825% |
| Biodesix, Inc. | 60.69 Million USD | 96.096% |
| BioNexus Gene Lab Corp. | 133.39 Thousand USD | -1676.219% |
| Precipio, Inc. | 1.11 Million USD | -112.311% |
| iSpecimen Inc. | 196.24 Thousand USD | -1107.368% |
| Natera, Inc. | 441.99 Million USD | 99.464% |
| Aspira Women's Health Inc. | 2.26 Million USD | -4.563% |
| Standard BioTools Inc. | 98.21 Million USD | 97.587% |
| 23andMe Holding Co. | 76.51 Million USD | 96.903% |
| Castle Biosciences, Inc. | 15.31 Million USD | 84.524% |
| Personalis, Inc. | 48.96 Million USD | 95.161% |
| Aclaris Therapeutics, Inc. | 426 Thousand USD | -456.194% |
| Applied DNA Sciences, Inc. | 1.23 Million USD | -91.425% |
| OpGen, Inc. | 13.04 Million USD | 81.835% |
| T2 Biosystems, Inc. | 49.49 Million USD | 95.213% |
| Myriad Genetics, Inc. | 145 Million USD | 98.366% |
| ICON Public Limited Company | 3.93 Billion USD | 99.94% |
| NeoGenomics, Inc. | 611.67 Million USD | 99.613% |
| Star Equity Holdings, Inc. | 3.6 Million USD | 34.348% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 99.75% |
| RadNet, Inc. | 1.49 Billion USD | 99.841% |
| MDxHealth SA | 41.26 Million USD | 94.258% |
| Psychemedics Corporation | 2.29 Million USD | -3.107% |
| Illumina, Inc. | 2.26 Billion USD | 99.895% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 94.06 Million USD | 97.481% |
| DarioHealth Corp. | 29.54 Million USD | 91.979% |
| Fulgent Genetics, Inc. | 14.9 Million USD | 84.106% |
| Sera Prognostics, Inc. | 1.85 Million USD | -27.524% |
| ENDRA Life Sciences Inc. | 394.4 Thousand USD | -500.753% |
| OPKO Health, Inc. | 326.56 Million USD | 99.274% |
| Medpace Holdings, Inc. | 142.12 Million USD | 98.333% |
| Neogen Corporation | 906.23 Million USD | 99.739% |
| Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -171.893% |
| Prenetics Global Limited | 2.36 Million USD | 0.0% |
| Mainz Biomed B.V. | 7.42 Million USD | 68.071% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -50.091% |
| Trinity Biotech plc | 67.42 Million USD | 96.486% |
| Neuronetics, Inc. | 62.47 Million USD | 96.207% |
| Sotera Health Company | 2.32 Billion USD | 99.898% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -50.091% |